In pancreatic cancer, TNC triggers the JNK/c-Jun signaling pathway, enhancing c-Jun binding to the MMP9 promoter, thus increasing MMP9 expression levels and activity (Cai et al., 2017). This evidence concerns the gene MMP9 and pancreatic neoplasm.